Cargando…

COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has plagued the Middle East since it was first reported in 2012. Recently, at the end of December 2019, a cluster of pneumonia cases were reported from Wuhan city, Hubei Province, China, linked to a wet seafood market with a new coronavirus ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Barry, Mazin, Al Amri, Maha, Memish, Ziad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310806/
https://www.ncbi.nlm.nih.gov/pubmed/32175703
http://dx.doi.org/10.2991/jegh.k.200218.003
_version_ 1783549429449490432
author Barry, Mazin
Al Amri, Maha
Memish, Ziad A.
author_facet Barry, Mazin
Al Amri, Maha
Memish, Ziad A.
author_sort Barry, Mazin
collection PubMed
description Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has plagued the Middle East since it was first reported in 2012. Recently, at the end of December 2019, a cluster of pneumonia cases were reported from Wuhan city, Hubei Province, China, linked to a wet seafood market with a new coronavirus identified as the etiologic agent currently named SARS-CoV-2. Most cases are in Mainland China with international spread to 25 countries. The novelty of the virus, the rapid national and international spread, and the lack of therapeutic and preventative strategies have led the WHO International Health Regulation emergency committee to declare the disease as Public Health Emergency of International Concern (PHEIC) on January 30, 2020. As it relates to countries with the ongoing MERS-CoV community cases and hospital acquired infections, there will be a huge challenge for HCWs to deal with both coronaviruses, especially with the lack of standardized and approved point of care testing. This challenge will now be faced by the whole global health community dealing with COVID-19 since both coronaviruses have similar presentation. Those patients should now be tested for both MERS-CoV and SARS-CoV-2 simultaneously, and with the continuing wide international spread of SARS-CoV-2, the travel history to China in the last 14 days will be of less significance
format Online
Article
Text
id pubmed-7310806
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Atlantis Press
record_format MEDLINE/PubMed
spelling pubmed-73108062020-07-28 COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia Barry, Mazin Al Amri, Maha Memish, Ziad A. J Epidemiol Glob Health Commentary Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has plagued the Middle East since it was first reported in 2012. Recently, at the end of December 2019, a cluster of pneumonia cases were reported from Wuhan city, Hubei Province, China, linked to a wet seafood market with a new coronavirus identified as the etiologic agent currently named SARS-CoV-2. Most cases are in Mainland China with international spread to 25 countries. The novelty of the virus, the rapid national and international spread, and the lack of therapeutic and preventative strategies have led the WHO International Health Regulation emergency committee to declare the disease as Public Health Emergency of International Concern (PHEIC) on January 30, 2020. As it relates to countries with the ongoing MERS-CoV community cases and hospital acquired infections, there will be a huge challenge for HCWs to deal with both coronaviruses, especially with the lack of standardized and approved point of care testing. This challenge will now be faced by the whole global health community dealing with COVID-19 since both coronaviruses have similar presentation. Those patients should now be tested for both MERS-CoV and SARS-CoV-2 simultaneously, and with the continuing wide international spread of SARS-CoV-2, the travel history to China in the last 14 days will be of less significance Atlantis Press 2020-03 2020-02-21 /pmc/articles/PMC7310806/ /pubmed/32175703 http://dx.doi.org/10.2991/jegh.k.200218.003 Text en © 2020 The Authors. Published by Atlantis Press International B.V. This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Commentary
Barry, Mazin
Al Amri, Maha
Memish, Ziad A.
COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
title COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
title_full COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
title_fullStr COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
title_full_unstemmed COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
title_short COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia
title_sort covid-19 in the shadows of mers-cov in the kingdom of saudi arabia
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310806/
https://www.ncbi.nlm.nih.gov/pubmed/32175703
http://dx.doi.org/10.2991/jegh.k.200218.003
work_keys_str_mv AT barrymazin covid19intheshadowsofmerscovinthekingdomofsaudiarabia
AT alamrimaha covid19intheshadowsofmerscovinthekingdomofsaudiarabia
AT memishziada covid19intheshadowsofmerscovinthekingdomofsaudiarabia